UMMS Announces Retirement of UMMC President and CEO Jeffrey Rivest

For immediate release: July 29, 2015

Contact:

Karen Lancaster

media@umm.edu

John Ashworth Named Interim Chief Executive

jeffrey rivest

Jeffrey A. Rivest, FACHE

BALTIMORE – Jeffrey A. Rivest, who has served as president and chief executive officer of the University of Maryland Medical Center (UMMC) since 2004, will be retiring at the end of August 2015. UMMC is the flagship academic medical center of the University of Maryland Medical System (UMMS).

“On behalf of the UMMS and UMMC family, I want to thank Jeff for his outstanding contributions over the last 11 years,” said Robert A. Chrencik, president and CEO of UMMS. “Under Jeff’s leadership, the Medical Center has continued to see its profile rise as one of our nation’s best academic medical centers. I am very proud of the teamwork and dedication that, under Jeff’s guidance, has fostered UMMC’s delivery of world-class time sensitive critical care medicine. ”

John Ashworth, currently the UMMS senior vice president for network development, will serve as the interim UMMC president and chief executive officer beginning Saturday, August 29th. Ashworth has previously served as UMMC president and chief executive officer, as well as director of the R Adams Cowley Shock Trauma Center. A search committee for a permanent president and CEO will be formed with representation of both the UMMS and UMMC boards, as well as partners from the University of Maryland School of Medicine. Rivest will remain an advisor during the interim period.

“Jeff's leadership has been integral to the growth and success of the Medical Center for over a decade,” said Louise Michaux Gonzales, Esq., chair of the UMMC Board of Directors. “I am particularly grateful this last year for his guiding hand in the establishment of the new Board of Directors. We will miss him.”  

“After 11 years as CEO and 40 years in health care leadership, now is the right time for me to pursue many personal interests I have deferred for far too long,” said Rivest.  “I am excited about what the future holds for UMMC and its talented and caring staff at all levels. UMMC and UMMS are very well-positioned to deal with the many challenges facing the health care field today. The future is very bright.” 

About the University of Maryland Medical Center

The University of Maryland Medical Center (UMMC) is comprised of two hospitals in Baltimore: an 800-bed teaching hospital — the flagship institution of the 12-hospital University of Maryland Medical System (UMMS) — and a 200-bed community teaching hospital, UMMC Midtown Campus. UMMC is a national and regional referral center for trauma, cancer care, neurocare, cardiac care, diabetes and endocrinology, women's and children's health and has one of the largest solid organ transplant programs in the country. All physicians on staff at the flagship hospital are faculty physicians of the University of Maryland School of Medicine. At UMMC Midtown Campus, faculty physicians work alongside community physicians to provide patients with the highest quality care. UMMC Midtown Campus was founded in 1881 and is located one mile away from the University Campus hospital. For more information, visit www.umm.edu.

About the University of Maryland Medical System

The University of Maryland Medical System (UMMS) currently includes 12 health systems and hospitals across Maryland including the University of Maryland Baltimore Washington Medical Center; University of Maryland Charles Regional Medical Center; University of Maryland Medical Center; University of Maryland Medical Center Midtown Campus; University of Maryland Rehabilitation & Orthopaedic Institute; University of Maryland Shore Health System; University of Maryland St. Joseph Medical Center; and University of Maryland Upper Chesapeake Health System, as well as the freestanding University of Maryland Shore Emergency Center at Queenstown and the University of Maryland Shore Nursing & Rehabilitation Center in Chestertown. UMMS also operates Mt. Washington Pediatric Hospital as a joint venture with Johns Hopkins.